Clinical Trials in Los Angeles

Showing 5421-5440 of 16,901 trials

Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake

NCT05586178

This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booster uptake.

COVID-19Vaccines

University of California, Los Angeles177,720 participantsStarted Oct 2022

Los Angeles, California, United States

Active Not RecruitingPhase 2< 1 mile

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

NCT06119217

This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with chemotherapy (gemcitabine + nab-paclitaxel) in subjects with metastatic PDAC who did not have prior treatment for metastatic disease and are eligible to receive gemcitabine and nab-paclitaxel chemotherapy as SOC.

Pancreatic Cancer

Trishula Therapeutics, Inc.194 participantsStarted Mar 2024

Tucson, Arizona, United States • Hot Springs, Arkansas, United States • Bakersfield, California, United States +61 more locations

Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Find Trials by Condition in Los Angeles

Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Human Laboratory Study of ASP8062 for Alcohol Use Disorder

Open Abdomen Study Comparing ABThera™ Open Abdomen Negative Pressure Therapy System and Barker's Vacuum Packing Technique

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy

Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke

Hyrax Vs. Invisalign Palatal Expander Clinical Study

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens

Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors

Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta